Conavi Medical Corp.
CNVI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.89M | -11.63M | -14.71M | -21.57M | -28.52M |
| Total Depreciation and Amortization | 512.20K | 532.20K | 556.00K | 530.10K | 558.60K |
| Total Amortization of Deferred Charges | 43.20K | 33.90K | 25.30K | 81.90K | 68.90K |
| Total Other Non-Cash Items | -373.00K | -2.28M | -1.10M | 4.47M | 8.17M |
| Change in Net Operating Assets | -4.38M | -1.47M | -2.76M | -1.16M | 3.68M |
| Cash from Operations | -17.09M | -14.80M | -17.99M | -17.65M | -16.04M |
| Capital Expenditure | -37.40K | -52.60K | -51.80K | -160.40K | -235.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -221.20K | -152.00K | 2.60M | 2.63M | 2.61M |
| Cash from Investing | -258.60K | -204.60K | 2.55M | 2.47M | 2.37M |
| Total Debt Issued | -- | -- | -- | 3.53M | 8.19M |
| Total Debt Repaid | -1.71M | -1.59M | -1.53M | -1.40M | -1.20M |
| Issuance of Common Stock | 22.95M | 12.11M | 22.20M | 22.20M | 10.09M |
| Repurchase of Common Stock | -40.00K | -40.00K | -40.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.30M | 6.30M | 6.30M | 6.33M | -- |
| Cash from Financing | 19.84M | 12.14M | 19.40M | 22.12M | 12.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.49M | -2.86M | 3.96M | 6.95M | -1.32M |